Low serum phosphate levels are related to increased cardiovascular risk in HIV-1 infected patients by Grima, P et al.
POSTER PRESENTATION Open Access
Low serum phosphate levels are related to
increased cardiovascular risk in HIV-1 infected
patients
P Grima
1*, M Guido
2, R Chiavaroli
1, P Tundo
1, A Zizza
3
From Tenth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 7-11 November 2010
Purpose of the study
Hypophosphatemia may contribute directly to the devel-
opment of obesity, hypertension and dyslipidemia.
Hyperglycemia, insulin resistance, hyperlipidemia and
hypertension, which are components of metabolic syn-
drome, are also recognized as strong risk factors for car-
diovascular disease [1]. This study was performed to
determine whether serum phosphate levels are asso-
ciated with increased risk for cardiovascular events.
Methods
We enrolled 125 consecutive HIV-1-infected patients in
a cross-sectional study. All patients were receiving
highly active antiretroviral therapy (HAART) for more
than six months. Fasting phosphate, lipids (cholesterol,
HDL, triglycerides), Homeostasis Model Assessment
(HOMA), blood pressure were evaluated. Framingham
10 years risk of general cardiovascular disease was used
to assess three cardiovascular risk (CVR) categories (low
CVR < 10%, medium CVR between 10 and 20%, high
CVR > 20%).
Summary of results
We observed a statistically significant decrease in serum
phosphate levels in the three different CVR groups (low
risk: 3.5 mg/dl; medium risk: 3.3 mg/dl; high risk: 2.9
mg/dl; p=0.001). There was a strong negative correlation
between Framingham score and phosphate levels (r:-
0.37, p<0.0001). Figure 1
Multiple regression analysis, including age, months of
HAART, CD4 cells count, cholesterol, HDL, HOMA,
systolic pressure, months of Tenofovir use, showed that
only HOMA (r:-0.30, p<0.01) and age (r:-0.3, p<0.01)
were the most important determinants of serum phos-
phate values.
Conclusions
We found that lower phosphate level is correlated with
cardiovascular risk and insulin resistance. Therefore,
when serum phosphate levels are too low the patients is
at risk for cardiovascular events and/or metabolic
syndrome.
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